Ribosome biogenesis: Achilles heel of cancer?
作者信息
van Sluis Marjolein, McStay Brian
机构信息
Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway.
出版信息
Genes Cancer. 2014 May;5(5-6):152-3. doi: 10.18632/genesandcancer.14.
Abstract
摘要
相似文献
1
Ribosome biogenesis: Achilles heel of cancer?
Genes Cancer. 2014 May;5(5-6):152-3. doi: 10.18632/genesandcancer.14.
2
Surgical reconstruction of the fascia lata and posterior tibial artery perforator flap to treat children with simultaneous injury to the Achilles tendon and heel skin.
Medicine (Baltimore). 2018 Feb;97(6):e9834. doi: 10.1097/MD.0000000000009834.
3
Efficacy of heel lifts versus calf muscle eccentric exercise for mid-portion Achilles tendinopathy (the HEALTHY trial): study protocol for a randomised trial.
J Foot Ankle Res. 2019 Mar 21;12:20. doi: 10.1186/s13047-019-0325-2. eCollection 2019.
4
Achilles Tendon Loading During Heel-Raising and -Lowering Exercises.
J Athl Train. 2017 Feb;52(2):89-96. doi: 10.4085/1062-6050-52.1.04. Epub 2017 Feb 1.
5
Efficacy of heel lifts for mid-portion Achilles tendinopathy (the LIFT trial): study protocol for a randomised controlled trial.
Trials. 2024 May 24;25(1):345. doi: 10.1186/s13063-024-08185-8.
6
The Effect of an In-shoe Orthotic Heel Lift on Loading of the Achilles Tendon During Shod Walking.
J Orthop Sports Phys Ther. 2016 Feb;46(2):79-86. doi: 10.2519/jospt.2016.6030. Epub 2016 Jan 11.
7
Females present larger deficit in heel-rise height at 3 months following an Achilles tendon rupture compared with males.
Knee Surg Sports Traumatol Arthrosc. 2024 Oct;32(10):2581-2588. doi: 10.1002/ksa.12208. Epub 2024 Apr 23.
8
Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial.
Arthritis Res Ther. 2022 May 16;24(1):111. doi: 10.1186/s13075-022-02797-8.
9
Deficits in heel-rise height and achilles tendon elongation occur in patients recovering from an Achilles tendon rupture.
Am J Sports Med. 2012 Jul;40(7):1564-71. doi: 10.1177/0363546512447926. Epub 2012 May 16.
10
Partial Heel Pad Avulsion with Open Calcaneal Tuberosity Fracture with Tendo-achilles Rupture: A Case Report.
J Orthop Case Rep. 2016 Sep-Oct;6(4):44-48. doi: 10.13107/jocr.2250-0685.564.
引用本文的文献
1
RACK1 MARylation regulates translation and stress granules in ovarian cancer cells.
J Cell Biol. 2025 Feb 3;224(2). doi: 10.1083/jcb.202401101. Epub 2025 Jan 6.
2
A PARP14/TARG1-Regulated RACK1 MARylation Cycle Drives Stress Granule Dynamics in Ovarian Cancer Cells.
bioRxiv. 2024 Sep 4:2023.10.13.562273. doi: 10.1101/2023.10.13.562273.
3
Targeting the oncogenic TBX3:nucleolin complex to treat multiple sarcoma subtypes.
Am J Cancer Res. 2021 Nov 15;11(11):5680-5700. eCollection 2021.
4
Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets.
NAR Cancer. 2020 Dec 22;2(4):zcaa035. doi: 10.1093/narcan/zcaa035. eCollection 2020 Dec.
5
Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers.
Cell. 2021 Aug 19;184(17):4531-4546.e26. doi: 10.1016/j.cell.2021.07.005. Epub 2021 Jul 26.
6
Targeting cancer via ribosome biogenesis: the cachexia perspective.
Cell Mol Life Sci. 2021 Aug;78(15):5775-5787. doi: 10.1007/s00018-021-03888-6. Epub 2021 Jul 1.
7
Recent advances in the nucleolar responses to DNA double-strand breaks.
Nucleic Acids Res. 2020 Sep 25;48(17):9449-9461. doi: 10.1093/nar/gkaa713.
8
Therapeutic Approaches Targeting Nucleolus in Cancer.
Cells. 2019 Sep 16;8(9):1090. doi: 10.3390/cells8091090.
9
Keeping ribosomal DNA intact: a repeating challenge.
Chromosome Res. 2019 Mar;27(1-2):57-72. doi: 10.1007/s10577-018-9594-z. Epub 2018 Dec 17.
10
Nucleolus and chromatin.
Histochem Cell Biol. 2018 Sep;150(3):209-225. doi: 10.1007/s00418-018-1696-3. Epub 2018 Jul 25.
本文引用的文献
1
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response.
Oncotarget. 2014 Jun 30;5(12):4361-9. doi: 10.18632/oncotarget.2020.
2
A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.
Cancer Cell. 2014 Jan 13;25(1):77-90. doi: 10.1016/j.ccr.2013.12.009.
3
Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling.
Sci Signal. 2012 Sep 11;5(241):pe38. doi: 10.1126/scisignal.2003477.
4
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Cancer Cell. 2012 Jul 10;22(1):51-65. doi: 10.1016/j.ccr.2012.05.019.
5
Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
Cancer Res. 2011 Feb 15;71(4):1418-30. doi: 10.1158/0008-5472.CAN-10-1728. Epub 2010 Dec 15.
6
The nucleolus under stress.
Mol Cell. 2010 Oct 22;40(2):216-27. doi: 10.1016/j.molcel.2010.09.024.
7
Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents.
PLoS One. 2010 Sep 27;5(9):e12996. doi: 10.1371/journal.pone.0012996.
8
Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.
J Biol Chem. 2010 Apr 16;285(16):12416-25. doi: 10.1074/jbc.M109.074211. Epub 2010 Feb 16.
Zotero 插件